Steatohepatitis/Metabolic Liver Disease News

Combining therapies with different mechanisms of action to treat non-alcoholic fatty liver disease resulted in greater reduction in liver-related measures, according to a presenter at The Liver Meeting Digital Experience.

Patients with nonalcoholic steatohepatitis with advanced fibrosis experienced fibrosis regression after treatment with aldafermin, according to research presented at The Liver Meeting Digital Experience.

Performing sequential non-invasive tests more accurately measured severity of fatty liver than single tests or simultaneous tests, according to a researcher at The Liver Meeting Digital Experience.

Using genetic markers with metabolic risk factors can predict an individual patient’s risk for developing liver related events due to non-alcoholic fatty liver disease, according to a researcher at The Liver Meeting Digital Experience.

Efruxifermin, a fibroblast growth factor-21 analog, helped patients with non-alcoholic steatohepatitis achieve reductions in liver fat and improved liver histology, lipid metabolism and glycemic control, according to research presented at The Liver Meeting Digital Experience.

Evaluating patients within 30 days of referral for liver transplantation reduces pre-procedure mortality, according to research presented at The Liver Meeting Digital Experience.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, explained findings from a study exploring metabolic issues and rheumatoid arthritis.

Most children with obesity who are at high risk for non-alcoholic fatty liver disease are not being screened, possibly leading to underdiagnosis of the condition, according to a speaker at ObesityWeek Interactive.

Cannabis use correlated with a decreased prevalence and progression of steatohepatitis among patients who were obese, according to results presented at the American College of Gastroenterology Virtual Annual Meeting.

Weight loss after a laparoscopic sleeve gastrectomy correlated with significant improvements in metabolic parameters, liver enzyme levels and liver histopathology, according to study results.